Skip to main content
Fig. 4 | Diabetology & Metabolic Syndrome

Fig. 4

From: Comparing angiotensin receptor–neprilysin inhibitors with sodium–glucose cotransporter 2 inhibitors for heart failure with diabetes mellitus

Fig. 4

Mean and standard error of left ventricular ejection fraction (A), left ventricular end-diastolic diameter (B), left ventricular end-systolic diameter (C), and left atrium diameter (D) during follow-up measurements of patients who received ARNI versus SGLT2i treatment in the IPTW-adjusted cohort. ARNI angiotensin receptor–neprilysin inhibitor, IPTW inverse probability treatment weighting, SGLT2i sodium–glucose cotransporter 2 inhibitors

Back to article page